Palliative Care: A Compassionate Approach for Mesothelioma Patients

Palliative Care: A Compassionate Approach for Mesothelioma Patients

Palliative care is a specialized medical approach focused on improving the quality of life for patients with serious illnesses. Palliative care plays a crucial role in supporting individuals with mesothelioma.

Living with Mesothelioma

Mesothelioma is a rare and aggressive cancer linked to asbestos exposure. It poses significant challenges to those diagnosed and their loved ones. The disease affects the lining of the lungs (pleura). But it can also occur in the lining of the abdomen (peritoneum) and other organs. Mesothelioma has an average survival rate ranging from 8 to 14 months post-diagnosis. Managing the physical, emotional, and practical aspects of this condition is important.

Unlike hospice care, palliative care can be initiated at any point after diagnosis. It usually takes place alongside curative treatments. Hospice care is only typically provided in the final stages of life.

The Role of Palliative Care

The goal of palliative care is to ease symptoms and side effects. It also can manage pain and address the psychosocial and spiritual needs of patients. A team of healthcare professionals, including doctors, nurses, social workers, and chaplains, work together to provide holistic support.

While this care does not aim to cure the disease, it can significantly improve a patient’s quality of life. It can help manage many symptoms. These may include such as shortness of breath, pain, fatigue, and loss of appetite. Palliative care helps patients better cope with their condition and its treatment.

A recent study conducted at The Ottawa Hospital in Canada examined the impact of palliative care on mesothelioma patients. The study included 223 patients diagnosed between 2002 and 2019. It found that while the use of care services increased over time, only 39.8% of patients received palliative care.

The study also found that there was no significant difference in survival between patients who received palliative care and those who did not. These findings suggest that care can manage symptoms and improve quality of life. But, it may not impact the overall survival of mesothelioma patients.

Yet, early integration of palliative care can help reduce suffering. It can also improve symptom control and enhance the well-being of patients and their families.

Palliative care is a valuable and compassionate approach for individuals living with mesothelioma. It provides comprehensive support and addresses the diverse needs of patients. This care enhances the quality of life and ensures dignity and comfort throughout the journey of living with this challenging disease.

Source:

Baird, Andrew, Abdullah Nasser, Peter Tanuseputro, Colleen Webber, Paul Wheatley-Price, and Camille Munro. “Involvement of Palliative Care in Malignant Pleural Mesothelioma Patients and Associations with Survival and End-of-Life Outcomes.” Current Oncology 31, no. 2 (February 2024): 1028–34. https://doi.org/10.3390/curroncol31020076.

Similar Posts

  • |

    Chemical in Wine May Improve Mesothelioma Treatment

    There’s new evidence that a compound found in red wine may help improve the effectiveness of chemotherapy treatment for malignant pleural mesothelioma. Last year, a team of Korean researchers released the world’s first study on the mesothelioma-fighting power of resveratrol, a natural phenol derived from the skin of red grapes and found in red wine and grape juice. Now, the same team says resveratrol also appears to enhance the chemosensitivity of malignant mesothelioma cells. Study author Yoon-Jin Lee and colleagues discovered  a synergistic cancer-fighting effect in mesothelioma cells treated with both resveratrol and clofarabine, a prescription drug often used to treat acute lymphoblastic leukemia. Together, resveratrol and clofarabine “induced a strong cytotoxic effect” by influencing levels of the tumor suppressor,…

  • |

    Mesothelioma Symptoms May Benefit from Tuberculosis Drugs

    Pleural effusion is the one of most uncomfortable and life-limiting symptoms of pleural mesothelioma. The buildup of fluid in the pleural space around the lungs, which can happen in late stage mesothelioma as well as several other types of cancer, limits breathing and can be painful. Effusion is often one of the primary reasons that mesothelioma patients in the late stages of the disease have trouble taking a full breath and complain of chest pain and fatigue. While pleural fluid can be drained off through thoracentesis or chemically absorbed through pleurodesis, these treatments are painful, risky, and not always effective. Now, a team of researchers in China say they may have discovered a non-invasive method for dealing with pleural effusion caused…

  • |

    Green Tea, Vitamin C, Chemo Fight Mesothelioma ‘Synergistically’

    Another study has found that the beneficial compounds in green tea may be powerful mesothelioma fighters – especially when combined with other drugs and nutrients. Epigallocatechin gallate (EGCG) is the most abundant polyphenol in green tea and is a potent antioxidant. A number of studies have suggested that it may help the body combat various types of cancer, including mesothelioma. Recently, a group of Italian mesothelioma researchers combined EGCG with Vitamin C and a chemotherapy drug called gemcitabine to create a treatment combination called AND (Active Nutrients/Drug). To test the mixture, they administered AND to various mesothelioma cell lines in the laboratory. The result was a “synergistic cytotoxic mechanism”, meaning the ingredients in AND seemed to increase each other’s cancer-fighting properties…

  • |

    Green Tea Component Fights Mesothelioma

    Another study appears to confirm the idea that a compound found in green tea may be a powerful tool for combatting malignant pleural mesothelioma. Epigallocatechin-3-gallate (EGCG) is a potent antioxidant found in abundance in green (though, not black) tea. It has long been thought to help fight cancer and other diseases by reducing the so-called free radicals produced during oxidative stress. Now, a new study conducted in Japan and published in Cancer Cell International finds that EGCG triggered cell death in five different human mesothelioma cell lines by doing just the opposite. “We found that EGCG induced apoptosis (cell death) in all five mesothelioma cell lines in a dose-dependent manner,” write the authors in a summary of their findings. “We further…

  • |

    Medicinal Plant for Mesothelioma?

    A new study suggests that a plant used for centuries in Indian Ayurvedic medicine may be a powerful weapon in the fight against deadly malignant mesothelioma. The bioactive compound Withaferin A (WA) is isolated from the root of Withania somnifera, a plant in the nightshade family also known as Indian ginseng.  A number of previous scientific studies have found evidence to suggest that WA has anti-inflammatory, immuno-modulatory, anti-angiogenic, and anti-cancer properties. In the latest study, published online in the open-access peer-reviewed journal PLos One, researchers at the Karmanos Cancer Institute in Detroit tested the compound in live mice (in vivo) as well as in mesothelioma cells taken from human patients (in vitro). Their objective was to determine whether WA would have…

  • |

    Mesothelioma Patients May Be Low in Antioxidants

    New research suggests that the antioxidant vitamins found in abundance in fruits and vegetable may have a protective effect against malignant pleural mesothelioma. The news comes from a University in Turkey, where environmentally-induced mesothelioma is alarmingly common due to high erionite content in some small towns. Erionite is a naturally-occurring mineral that is structurally similar to asbestos, the primary cause of mesothelioma around the world. Erionite not only exists in the soil in these Turkish towns, but is also incorporated into hundreds of homes built from erionite-laden rocks. In an effort to evaluate whether or not certain key antioxidant vitamins might protect people against the deadly cancer, Turkish researchers enrolled 160 subjects, 42 of whom had been diagnosed with malignant pleural…